150 related articles for article (PubMed ID: 36117441)
1. Anaemia can be improved by controlling the disease activity of Takayasu's arteritis without iron administration.
Guo Y; Du J; Li T; Gao N; Pan L
Int J Lab Hematol; 2023 Feb; 45(1):112-118. PubMed ID: 36117441
[TBL] [Abstract][Full Text] [Related]
2. Paediatric-onset Takayasu's arteritis associates with worse survival than adult-onset Takayasu's arteritis. A matched retrospective cohort study.
Misra DP; Thakare DR; Mishra P; Rathore U; Singh K; Behera MR; Jain N; Ora M; Bhadauria DS; Gambhir S; Kumar S; Agarwal V
Clin Exp Rheumatol; 2024 Apr; 42(4):914-922. PubMed ID: 37584395
[TBL] [Abstract][Full Text] [Related]
3. Cyclophosphamide could be a better choice than methotrexate as induction treatment for patients with more severe Takayasu's arteritis.
Sun Y; Ma L; Ma L; Kong X; Chen H; Lv P; Lin J; Liu H; Yan Y; Ji Z; Yang C; Dai S; Wan W; Zou Y; Jin X; Jiang L
Rheumatol Int; 2017 Dec; 37(12):2019-2026. PubMed ID: 29030659
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil in Takayasu's arteritis.
Goel R; Danda D; Mathew J; Edwin N
Clin Rheumatol; 2010 Mar; 29(3):329-32. PubMed ID: 20054700
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum 25-hydroxyvitamin D: a potential indicator of remission in Takayasu arteritis patients with normal ESR and CRP levels.
Liao H; Du J; Li F; Yang S; Qi G; Pan L
Clin Rheumatol; 2024 Jun; 43(6):1979-1987. PubMed ID: 38598024
[TBL] [Abstract][Full Text] [Related]
6. Performance of the PET vascular activity score (PETVAS) for qualitative and quantitative assessment of inflammatory activity in Takayasu's arteritis patients.
Kang F; Han Q; Zhou X; Zheng Z; Wang S; Ma W; Zhang K; Quan Z; Yang W; Wang J; Zhu P
Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3107-3117. PubMed ID: 32567005
[TBL] [Abstract][Full Text] [Related]
7. Assessment of damage in Takayasu's arteritis.
Kaymaz-Tahra S; Alibaz-Oner F; Direskeneli H
Semin Arthritis Rheum; 2020 Aug; 50(4):586-591. PubMed ID: 32470706
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of B cells and immunoglobulin profile in Takayasu's arteritis.
Ci W; Li T; Du J; Fang W; Chen D; Han L; Dong R; Cao J; Pan L
Clin Exp Rheumatol; 2023 Apr; 41(4):870-878. PubMed ID: 36533979
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with radiographic progression in patients with Takayasu's arteritis.
Lee S; Eun Y; Kim H; Lee J; Koh EM; Kim DK; Cha HS
Clin Exp Rheumatol; 2021; 39 Suppl 129(2):46-51. PubMed ID: 33635213
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of 251 patients with Takayasu arteritis on combination immunosuppressant therapy: Single centre experience from a large tertiary care teaching hospital in Southern India.
Goel R; Danda D; Joseph G; Ravindran R; Kumar S; Jayaseelan V; Jayaseelan L; Bacon P
Semin Arthritis Rheum; 2018 Apr; 47(5):718-726. PubMed ID: 29096935
[TBL] [Abstract][Full Text] [Related]
11. Clinical course of 602 patients with Takayasu's arteritis: comparison between Childhood-onset versus adult onset disease.
Danda D; Goel R; Joseph G; Kumar ST; Nair A; Ravindran R; Jeyaseelan L; Merkel PA; Grayson PC
Rheumatology (Oxford); 2021 May; 60(5):2246-2255. PubMed ID: 33179052
[TBL] [Abstract][Full Text] [Related]
12. Comparison of methotrexate and azathioprine as the first-line steroid-sparing immunosuppressive agents in patients with Takayasu's arteritis.
Kaymaz-Tahra S; Bayindir O; Ince B; Ozdemir İsik O; Kutu ME; Karakas O; Yildirim TD; Ademoglu Z; Ediboglu ED; Uludogan BCE; Ilgin C; Bilge NSY; Kasifoglu T; Akar S; Emmungil H; Onen F; Omma A; Kanitez NA; Yazici A; Cefle A; Inanc M; Aksu K; Keser G; Direskeneli H; Alibaz-Oner F
Semin Arthritis Rheum; 2024 Jun; 66():152446. PubMed ID: 38669786
[TBL] [Abstract][Full Text] [Related]
13. Poor obstetric outcomes in Indian women with Takayasu arteritis.
Gupta L; Misra DP; Ahmed S; Jain A; Zanwar A; Lawrence A; Agarwal V; Aggarwal A; Misra R
Adv Rheumatol; 2020 Mar; 60(1):17. PubMed ID: 32164787
[TBL] [Abstract][Full Text] [Related]
14. Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio associated with disease activity in patients with Takayasu's arteritis: a case-control study.
Pan L; Du J; Li T; Liao H
BMJ Open; 2017 May; 7(4):e014451. PubMed ID: 28473512
[TBL] [Abstract][Full Text] [Related]
15. Study on the association of serum pentraxin-3 and lysosomal-associated membrane protein-2 levels with disease activity in Chinese Takayasu's arteritis patients.
Chen Z; Hu C; Sun F; Li J; Yang Y; Tian X; Zeng X
Clin Exp Rheumatol; 2019; 37 Suppl 117(2):109-115. PubMed ID: 30943132
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the frequency of cardiovascular risk factors in patients with Takayasu's arteritis.
Alibaz-Oner F; Koster MJ; Unal AU; Yildirim HG; Çikikçi C; Schmidt J; Crowson CS; Makol A; Ytterberg SR; Matteson EL; Direskeneli H; Warrington KJ
Rheumatology (Oxford); 2017 Nov; 56(11):1939-1944. PubMed ID: 28968808
[TBL] [Abstract][Full Text] [Related]
17. Aneurysms in Takayasu's arteritis: a retrospective study of Chinese patients.
Cheng F; Shao Z; Lu QS; Zhao R; Lu FL; Tian B; Peng WJ; Zhao FT; Zhao DB; Cai Q
Clin Exp Rheumatol; 2020; 38 Suppl 124(2):42-47. PubMed ID: 31820727
[TBL] [Abstract][Full Text] [Related]
18. Association between acute phase reactants, interleukin-6, tumor necrosis factor-α, and disease activity in Takayasu's arteritis patients.
Li J; Wang Y; Wang Y; Wang Y; Yang Y; Zhao J; Li M; Tian X; Zeng X
Arthritis Res Ther; 2020 Dec; 22(1):285. PubMed ID: 33303010
[TBL] [Abstract][Full Text] [Related]
19. Risk assessment model for heart failure in Chinese patients with Takayasu's arteritis.
Wang YJ; Ma LL; Liu Y; Yan Y; Sun Y; Wang YS; Dai XM; Ji ZF; Ma LY; Chen HY; Jiang LD
Clin Rheumatol; 2021 Oct; 40(10):4117-4126. PubMed ID: 34021842
[TBL] [Abstract][Full Text] [Related]
20. The effects of biological agents on vascular structural lesions in Takayasu's arteritis.
Erbasan F; Uçar İ; Aslan B; Yazisiz V; Terzioğlu ME
Clin Exp Rheumatol; 2021; 39 Suppl 129(2):135-141. PubMed ID: 33506752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
